Glasgow, Scotland – 29 April 2026. EnteroBiotix Limited (‘EnteroBiotix’), a biopharmaceutical company developing best-in-class microbiome therapies for gut health, today announces the completion of a £19m ($25m) financing to advance its lead candidate, EBX-102-02, a next-generation orally delivered full-spectrum investigational microbiome therapeutic, into Phase 2b development for Irritable Bowel Syndrome with Constipation (IBS-C).
New findings uncover staggering triple-digit growth in state tax lien filings in New York, Georgia, Ohio, and more, signaling a tough new era of enforcement for taxpayers. New findings uncover staggering triple-digit growth in state tax lien filings in New York, Georgia, Ohio, and more, signaling a tough new era of enforcement for taxpayers.
METTAWA, Ill., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2026 third quarter financial results on Thursday, October 29, 2026, before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website. The results will also…
VANCOUVER, BRITISH COLUMBIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces that it has acquired additional contiguous claims to its Junker Property in the Toodoggone Gold & Copper District of northern British Columbia.
